Nuveen LLC acquired a new position in shares of The Clorox Company (NYSE:CLX – Free Report) during the 1st quarter, HoldingsChannel.com reports. The institutional investor acquired 287,269 shares of the company’s stock, valued at approximately $42,300,000.
Other institutional investors have also recently bought and sold shares of the company. OneDigital Investment Advisors LLC acquired a new position in Clorox during the first quarter worth $247,000. Brown Miller Wealth Management LLC acquired a new position in Clorox during the first quarter worth $399,000. Roman Butler Fullerton & Co. acquired a new position in Clorox during the first quarter worth $400,000. Wedge Capital Management L L P NC raised its holdings in Clorox by 33.5% during the first quarter. Wedge Capital Management L L P NC now owns 28,510 shares of the company’s stock worth $4,198,000 after buying an additional 7,159 shares during the last quarter. Finally, Cornerstone Wealth Group LLC raised its holdings in shares of Clorox by 19.0% in the first quarter. Cornerstone Wealth Group LLC now owns 25,582 shares of the company’s stock valued at $3,767,000 after purchasing an additional 4,085 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.
Wall Street Analyst Weigh In
Several brokerages have recently commented on CLX. Morgan Stanley lowered their target price on shares of Clorox from $150.00 to $137.00 and set an “equal weight” rating for the company in a report on Friday, August 1st. Citigroup reiterated a “neutral” rating and issued a $135.00 target price (down previously from $140.00) on shares of Clorox in a research note on Tuesday, July 15th. Evercore ISI set a $140.00 price objective on shares of Clorox and gave the company an “underperform” rating in a research note on Tuesday, May 6th. Jefferies Financial Group reduced their price objective on shares of Clorox from $167.00 to $145.00 and set a “buy” rating for the company in a research note on Thursday, June 26th. Finally, Barclays reduced their price objective on shares of Clorox from $129.00 to $119.00 and set an “underweight” rating for the company in a research note on Tuesday, July 15th. Three research analysts have rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, Clorox presently has an average rating of “Hold” and a consensus price target of $143.36.
Clorox Trading Up 0.5%
Shares of Clorox stock opened at $122.17 on Friday. The Clorox Company has a 1 year low of $117.35 and a 1 year high of $171.37. The firm has a market cap of $14.94 billion, a PE ratio of 18.74, a PEG ratio of 0.97 and a beta of 0.49. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The company has a 50 day simple moving average of $124.84 and a two-hundred day simple moving average of $136.64.
Clorox (NYSE:CLX – Get Free Report) last announced its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. During the same period in the previous year, the business posted $1.82 earnings per share. Clorox’s revenue for the quarter was up 4.5% on a year-over-year basis. Analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
Clorox Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Wednesday, August 13th will be paid a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a dividend yield of 4.1%. This is a boost from Clorox’s previous quarterly dividend of $1.22. The ex-dividend date of this dividend is Wednesday, August 13th. Clorox’s payout ratio is 76.07%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 Restaurant Stocks That Will Outperform in Q3 and Q4
- Breakout Stocks: What They Are and How to Identify Them
- The Midstream Energy Play That Keeps Powering Higher
- Investing in the High PE Growth Stocks
- Ethereum Near All-Time High: 3 Stocks Stacking ETH in Treasuries
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.